Biocon's Rosuvastatin Calcium tablets get EU approval to treat hyperlipidemia

Indian biopharmaceutical company Biocon has received approval from the European Commission for its Rosuvastatin Calcium tablets to treat hyperlipidemia or mixed dyslipidemia.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news